4.950
4.95 (0%)
As of Dec 20, 2024
Sagimet Biosciences Inc [SGMT]
Source:
Company Overview
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company developing novel therapeutics called fatty acid synthase inhibitors that target dysfunctional metabolic pathways in diseases resulting from the overproduction of the fatty acid, palmitate.
| Country | United States |
| Headquarters | san mateo, california |
| Phone Number | (650) 561-8600 |
| Industry | manufacturing |
| CEO | David Happel |
| Website | www.sagimet.com |